Varadi G - Search Results

1

The role of thiotepa in autologous bone marrow transplantation for acute leukemia.

Nagler A, Finlander R, Or R, Naparstek E, Varadi G, Slavin S. Nagler A, et al. Among authors: varadi g. Leuk Res. 1998 Nov;22(11):991-5. doi: 10.1016/s0145-2126(98)00102-7. Leuk Res. 1998. PMID: 9783800 Clinical Trial.

2

Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.

Or R, Ackerstein A, Nagler A, Amar A, Naparstek E, Varadi G, Kapelushnik J, Samuel S, Pugatsch T, Brautbar C, Slavin S. Or R, et al. Among authors: varadi g. J Immunother. 1998 Nov;21(6):447-53. doi: 10.1097/00002371-199811000-00007. J Immunother. 1998. PMID: 9807740 Clinical Trial.

3

The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.

Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, Slavin S, Nagler A. Rosales F, et al. Among authors: varadi g. Bone Marrow Transplant. 1999 May;23(9):861-5. doi: 10.1038/sj.bmt.1701758. Bone Marrow Transplant. 1999. PMID: 10338039

4

Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma.

Varadi G, Or R, Kapelushnik J, Naparstek E, Nagler A, Brautbar C, Amar A, Kirschbaum M, Samuel S, Slavin S, Siegal T. Varadi G, et al. Leuk Lymphoma. 1999 Jun;34(1-2):185-90. doi: 10.3109/10428199909083396. Leuk Lymphoma. 1999. PMID: 10350348

5

The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.

Rosales F, Naparstek E, Varadi G, Or R, Slavin S, Nagler A. Rosales F, et al. Among authors: varadi g. Leuk Res. 1999 Oct;23(10):947-52. doi: 10.1016/s0145-2126(99)00112-5. Leuk Res. 1999. PMID: 10573141

6

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.

Nagler A, Slavin S, Varadi G, Naparstek E, Samuel S, Or R. Nagler A, et al. Among authors: varadi g. Bone Marrow Transplant. 2000 May;25(10):1021-8. doi: 10.1038/sj.bmt.1702392. Bone Marrow Transplant. 2000. PMID: 10828860

7

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.

Nagler A, Or R, Naparstek E, Varadi G, Slavin S. Nagler A, et al. Among authors: varadi g. Exp Hematol. 2000 Sep;28(9):1096-104. doi: 10.1016/s0301-472x(00)00511-7. Exp Hematol. 2000. PMID: 11008023 Free article.

8

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.

Nagler A, Aker M, Or R, Naparstek E, Varadi G, Brautbar C, Slavin S. Nagler A, et al. Among authors: varadi g. Exp Hematol. 2001 Mar;29(3):362-70. doi: 10.1016/s0301-472x(00)00655-x. Exp Hematol. 2001. PMID: 11274765 Free article.

9

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.

Morecki S, Gelfand Y, Nagler A, Or R, Naparstek E, Varadi G, Engelhard D, Akerstein A, Slavin S. Morecki S, et al. Among authors: varadi g. Bone Marrow Transplant. 2001 Aug;28(3):243-9. doi: 10.1038/sj.bmt.1703118. Bone Marrow Transplant. 2001. PMID: 11535991

10

Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation.

Nagler A, Deutsch VR, Varadi G, Pick M, Eldor A, Slavin S. Nagler A, et al. Among authors: varadi g. Leuk Lymphoma. 1995 Oct;19(3-4):343-9. doi: 10.3109/10428199509107908. Leuk Lymphoma. 1995. PMID: 8535229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters